The Reck tumor suppressor protein alleviates tissue damage and promotes functional recovery after transient cerebral ischemia in mice.
The extracellular matrix (ECM) is important for both structural integrity and functions of the brain. Matrix metalloproteinases (MMPs) play major roles in ECM-remodeling under both physiological and pathological conditions. Reversion-inducing cysteine-rich protein with Kazal motifs (Reck) is a membrane-anchored MMP-regulator implicated in coordinated regulation of pericellular proteolysis. Although patho-physiological importance of MMPs and another group of MMP-regulators, tissue inhibitor of metalloproteinases, in brain ischemia has been demonstrated, little is known about the role of Reck in this process. In this study, we found that Reck is up-regulated in hippocampus and penumbra of subventricular zone after transient cerebral ischemia in mice. Most of the Reck-positive cells found at day 2 after ischemia are positive for Nestin as well as Ki67 and localized to the CA2 region of the hippocampus. At day 7 after ischemia, the Reck-positive cells increased in number, extended processes, expressed the reactive astrocyte marker GFAP and the neuronal marker NF200, and were widely distributed in the hippocampus. In the mutant mice carrying single functional Reck allele (Reck+/-), tissue damage and cell death after cerebral ischemia were augmented, the recovery of long-term potentiation in the hippocampus was compromised, NR2C subunit of NMDA receptor was up-regulated, gelatinolytic activity of MMPs were up-regulated and laminin-immunoreactivity was reduced. Our data implicate Reck in protection of ECM/tissue integrity and promotion of functional recovery in the brain after transient cerebral ischemia.
Wang
Huan
H
Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan.
Imamura
Yukio
Y
Ishibashi
Ryota
R
Chandana
Ediriweera P S
EP
Yamamoto
Mako
M
Noda
Makoto
M
D000818:Animals; D001703:Biophysics; D002452:Cell Count / Q000379:methods; D004195:Disease Models, Animal; D004558:Electric Stimulation; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D020287:In Situ Nick-End Labeling / Q000379:methods; D066298:In Vitro Techniques; D002546:Ischemic Attack, Transient / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D019394:Ki-67 Antigen / Q000378:metabolism; D034882:Lamins / Q000378:metabolism; D017774:Long-Term Potentiation / Q000235:genetics / Q000502:physiology; D008297:Male; D020782:Matrix Metalloproteinases / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018408:Patch-Clamp Techniques; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000235:genetics / Q000378:metabolism; D020127:Recovery of Function / Q000235:genetics / Q000502:physiology*; D025521:Tumor Suppressor Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation / Q000502:physiology*
D019394:Ki-67 Antigen; D034882:Lamins; C432823:NR2C NMDA receptor; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D012333:RNA, Messenger; D016194:Receptors, N-Methyl-D-Aspartate; D025521:Tumor Suppressor Proteins; D020782:Matrix Metalloproteinases